Android app on Google Play

Idenix Pharmaceuticals (IDIX) Reports In-Line Q4 Loss of 17c/Share

February 25, 2013 4:09 PM EST Send to a Friend
Get Alerts IDIX Hot Sheet
Price: $24.50 --0%

Financial Fact:
Research and development: 24.19M

Today's EPS Names:
GEF, CCUR, BYI, More
Trade IDIX Now!
Join SI Premium – FREE
Idenix Pharmaceuticals (NASDAQ: IDIX) reported Q4 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $327 thousand versus the consensus estimate of $740 thousand.

For earnings history and earnings-related data on Idenix Pharmaceuticals (IDIX) click here.




You May Also Be Interested In


Related Categories

Earnings

Related Entities

Earnings

Add Your Comment